Sutro Biopharma, Inc. (STRO) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of$0.42. This compares to a loss of $0.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -59.52$0.39 per share when it actually produced a loss of $0.14, delivering a surprise of +64.1%.Over the last four quarters, the company has ...